Trans-Asia announced earlier this month that it is planning to list its newly-spun-off subsidiary TAPET
in the PSE.
64 a share, Tapet
shares are up 16 percent from its listing price.
utilizes bioengineered Salmonella bacteria to deliver proteins and prodrug converting enzymes to tumor cells, and has exhibited significant anti-tumor activity alone (unarmed, or without drug) in preclinical studies.
We presented our TAPET
data for the first time at the American Association for Cancer Research annual meeting.
In a disclosure to the Philippine Stock Exchange, Tapet
(spun off from TransAsia Oil and Energy Development Corp.